COMPANY · LEADERSHIP

Executive Leadership Team

Leading nRichDX across business, science, commercial development, and research & development.

The executive leadership team brings together healthcare business experience, scientific leadership, product development, and commercial expertise to guide the company and advance the Revolution platform.

04
EXECUTIVE LEADERS
Business Science Commercial R&D
EXECUTIVE LEADERSHIP Science. Strategy. Execution.
OUR LEADERSHIP TEAM

Built around complementary expertise.

Bringing a liquid-biopsy sample-preparation platform forward requires more than one discipline.

nRichDX leadership combines healthcare business development, life-science research, product development, quality and design control, commercial development, and market strategy.

EXECUTIVE LEADERSHIP

Meet the team leading nRichDX.

Explore the experience and functional leadership behind the company’s business, scientific, commercial, and R&D direction.

William W. Curtis
01 EXECUTIVE LEADERSHIP

William W. Curtis

Chief Executive Officer

William Curtis is Chief Executive Officer of nRichDX and a member of its Board of Directors. William joined nRichDX in July 2015 and brings over 30 years of experience in the healthcare industry. He has exclusively been involved in healthcare business development and healthcare services since 1983.

Read Full Bio

Prior to joining nRichDX, William was the co-founder, Chairman and Chief Executive Officer of CBLPath Holdings Corporation, a specialized anatomic pathology and molecular laboratory that under his leadership experienced organic, profitable revenue growth from $4MM to $85+MM. Previously, he was the founder and Chief Executive Officer of MLC International and The Hillside Group, healthcare financial and business development companies.

Nafiseh Jafari, PhD
02 EXECUTIVE LEADERSHIP

Nafiseh Jafari, PhD

Chief Science Officer

Nafiseh Jafari, PhD is Chief Science Officer at nRichDX. Nafiseh joined nRichDX in January 2020 and has over 10 years of experience in life science research. She is a scientific leader with a passion for building and managing high-performance teams. Nafiseh has managed multimillion-dollar development projects leading to the successful creation and launch of multiple products. Her expertise in talent management and quality/design control systems make her a key member of the nRichDX team.

Read Full Bio

Immediately prior to joining nRichDX, Nafiseh was a Project Manager leading cross-functional teams at Abbott Diagnostics. She holds a B.S. degree in Chemistry from Sharif University of Technology and earned her Ph.D. degree in Biochemistry and Molecular Biology at Western Michigan University.

Kamran Syed
03 EXECUTIVE LEADERSHIP

Kamran Syed

Vice President - Commercial Development

Kamran Syed is Vice President of Sales at nRichDX. Kamran joined the team at nRichDX in January of 2021 and brings over 20 years of commercial experience with roles in Sales, Marketing, Sales Leadership, Business Development and Strategy at a myriad of leading Diagnostics and Life Science companies to include Abbott Laboratories, ThermoFisher Scientific, Cepheid, Novartis (Genoptix Medical Laboratories), Quest Diagnostics, Cardinal Health, and Illumina. As a Commercial Leader, Kamran has led teams to consistently exceed multimillion dollar revenue and profit targets.

Read Full Bio

Kamran is a seasoned biotechnology commercial executive that is passionate about and exceptionally skilled in building high-performance teams, market development, business development and sales and strategy execution, helping companies bring to market paradigm shifting molecular diagnostic and genomic technologies, and high medical value add therapies, which have the potential to transform how patient care is delivered.

Kamran holds a B.S. degree in Biology, with minors in Chemistry and Psychology from Loyola University of Chicago, and an MBA, with a focus in Healthcare Management from the University of Phoenix.

Mayer Saidian, PhD
04 EXECUTIVE LEADERSHIP

Mayer Saidian, PhD

Vice President - Research & Development

Mayer Saidian, PhD is Vice President of Research & Development for nRichDX. Mayer joined nRichDX in early 2020 and brings over 15 years of development experience in molecular biology and life sciences. Mayer is a scientific leader with passion for breakthrough technologies and combining cutting edge technologies and bringing them into the scientific and clinical worlds.

Read Full Bio

Prior to joining nRichDX, Mayer was conducting multi-disciplinary and international research at University of California, Irvine and Hebrew University in Jerusalem to develop non-invasive methodologies to diagnose internal diseases, such as diabetes, through the skin. Mayer used advanced technologies and machine learning skills to perform this study.

Mayer holds B.S. and M.S. degrees in biology and chemistry and earned his Ph.D. degree in Pharmacology at the Hebrew University in Jerusalem and University of California, Irvine.

All trademarks referenced in leadership biographies are the property of their respective owners.
LEADERSHIP ACROSS THE BUSINESS

Four functions. One company direction.

Complementary leadership across the functions required to move technology from development through commercialization.

01 BUSINESS

Corporate Leadership

Company direction, healthcare business development, and organizational growth.

02 SCIENCE

Scientific Leadership

Life-science research, development programs, quality systems, and product creation.

03 COMMERCIAL

Market Development

Sales, market development, business development, strategy, and commercial execution.

04 R&D

Technology Development

Molecular biology, multidisciplinary development, and translation of new technologies.

MORE nRichDX LEADERSHIP

Explore the people guiding the company.

Continue through the leadership and company pages to learn more about the people shaping nRichDX.

CONNECT WITH nRichDX

Learn more about the team, company, and Revolution platform.